newsfilter
← Latest News
GlobeNewswire·

CorMedix Therapeutics to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026

  • CorMedix Therapeutics (Nasdaq: CRMD) will report financial results for the third quarter ended September 30, 2026.
  • The company will announce results before the market opens on Thursday, November 12, 2026.
  • A corporate update conference call will be held at 8:30 a.m. Eastern Standard Time on November 12, 2026.
  • CorMedix is a biopharmaceutical company focused on developing & commercializing therapeutic products for life-threatening conditions in the United States.
  • The company operates a field-based medical & commercial infrastructure deployed in hospitals, clinics, & infusion centers.
  • Investor inquiries can be directed to Dan Ferry, Managing Director at LifeSci Advisors.
Company
CorMedix, Inc.
Keywords
Nasdaq:CRMD, CorMedix, Inc.